Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Eliem Therapeutics

Youtube Subscribe

...

Ticker: ELYM

Sector: Biotechnology

Eliem Therapeutics, Inc. focuses on developing therapies for neuronal excitability disorders. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, in preclinical for the treatment of.
...
...
Extended Summary

Eliem Therapeutics

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. The company was incorporated in 2018 and is headquartered in Redmond, Washington.

Related Results

...
January 01, 2024 22:39 (London Time)

Eliem Therapeutics

Eliem Therapeutics says it isfor strategic alternatives, including an acquisition, merger, business combination or another transaction. The company …
Sector: Biotechnology
Ticker: ELYM
Sentiment: 0.1779
MarketCap: 74,446,192.0
High: 2.81 Low: 2.69

Open: 2.76 Close: 2.7 Change: -0.06

Read more →
...
May 16, 2023 4:42 (London Time)

Eliem Therapeutics

Eliem Therapeutics Inc. (ELYM) GAAP EPS of -$0.84 (NASDAQ:ELYM): Q1 GAAP eps of - $0.85. Eliems presented initial preclinical data from ETX-123, Eli…
Sector: Biotechnology
Ticker: ELYM
Sentiment: 0.0
MarketCap: 86,316,400.0
High: 3.22 Low: 2.95

Open: 3.22 Close: 2.98 Change: -0.24

Read more →
Search
Happening Now
Categories